Feng Miao
Papers
2
Total Citations
75
H-Index
2
About
Dr. Feng Miao is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly robotic-assisted procedures for renal and prostate cancers. His most influential study, "Trends in Utilization of Robotic and Open Partial Nephrectomy for Management of cT1 Renal Masses" (2018), with 68 citations, systematically analyzed national practice patterns, demonstrating a significant shift toward robotic partial nephrectomy for small renal tumors. This work highlighted the procedure's growing adoption and its potential to improve patient outcomes while preserving renal function. Dr. Miao further contributed to perioperative care innovation through his 2021 study on "Safe transition to opioid-free pathway after robotic-assisted laparoscopic prostatectomy," which provided a practical framework for reducing opioid dependence in post-surgical recovery—a critical step in combating the opioid crisis. His research bridges surgical technique optimization and patient-centered care, offering evidence-based strategies that enhance recovery and minimize complications. By tracking real-world trends and championing opioid-sparing protocols, Dr. Miao has established himself as a leader in modern urologic oncology, shaping how surgeons approach kidney and prostate cancer treatment in the robotic era.
Research Focus
Key Achievements
Top Papers
- 1
- 2